Research Article
Volume 3 Issue 3 - 2021
Health Utility of Patients with Graves’ Disease after Two-Year Treatment with Anti-Thyroid Drugs and Radioactive Iodine: a Prospective Study
Phisan Chumchuen1*, Valeerat Vongkasem2 and Daranee Timkaew3
1Department of Medicine, Damnoen Saduak Hospital, Thailand
2Department of Pharmacy, Damnoen Saduak Hospital, Thailand
3Department of Nursing, Damnoen Saduak Hospital, Thailand
*Corresponding Author: Phisan Chumchuen, Damnoen Saduak hospital, Ratchaburi, Thailand.
Received: December 31, 2020; Published: February 19, 2021


Introduction: Graves’ disease (GD) is the most common cause of hyperthyroidism. Antithyroid hormone drugs (ATD) and radioactive iodine (RAI) are two popular treatments. Choosing treatment methods may lead to different outcomes of treatment.  

Objective: The study aimed to evaluate the therapeutic effect between the ATD and the RAI on health utility as an aspect of quality of life (QOL).

Method:  A prospective study was conducted.  A total of 182 patients with GD were enrolled in the study (151 and 31 patients treated with ATD and RAI, respectively) in Damnoen Saduak Hospital, Thailand, between July 2014 and July 2020. The health utility was measured using the EuroQol (EQ-5D). The comparison of the treatment outcomes between each treatment modality was made using the independent sample t-test.

Result: After two years of the following periods, the patients in the RAI treatment group showed a significant improvement in the QOL than that of the ATD group; in terms of the utility score (p=0.034) and remission rate (p < 0.01).

Conclusion: RAI demonstrated a better improvement of the health utility than ATD. RAI is suitable for first line treatment strategy for severe GD.


Keywords: Health Utility; Graves’ Disease; Anti-Thyroid Drugs; Radioactive Iodine; Quality of Life


    1. Bahn RS. “Autoimmunity and Graves Disease”. Clinical Pharmacology and Therapeutics4 (2012): 577-579.
    2. Panchavinnin Pariya., et al. “Prevalence of T3 Toxicosis in Thai Patients with Thyrotoxicosis 101 (2018).
    3. Bartalena Luigi. “Diagnosis and Management of Graves Disease: A Global Overview”. Nature Reviews Endocrinology12 (2013): 724-734.
    4. Sriphrapradang Chutintorn. “Diagnosis and Management of Graves’ Disease in Thailand: A Survey of Current Practice”. Journal of Thyroid Research (2020).
    5. Sakthong Phantipa. Health Qaulity of Life. Bangkok: Chulalongkorn university (2011).
    6. Elberling TV., et al. “Impaired Health-Related Quality of Life in Graves’ Disease. A Prospective Study”. European Journal of Endocrinology5 (2004): 549-555.
    7. Lee Sun Y. “Quality of Life Is Worse at 6-10 Years after Radioactive Iodine Treatment of Graves’ Disease as Compared with Antithyroid Drugs or Surgery”. Clinical Thyroidology4 (2019): 144-147.
    8. Mladenovic M., et al. “Health State Utilities in Individuals with Goiter, Hypothyroidism, Hyperthyroidism and Graves’ Disease as an Example for Thyroid Disorders - A Systematic Review”. Value in Health9 (2017): A483.
    9. Patrick Yeatts R. “Quality of Life in Patients with Graves Ophthalmopathy”. Transactions of the American Ophthalmological Society 103 (2005): 368-411.
    10. Elberling TV., et al. “Impaired Health-Related Quality of Life in Graves’ Disease. A Prospective Study”. European Journal of Endocrinology5 (2004): 549-555.
    11. Vongkasem Valeerat and Surasit Lochid-amnuay. “The Health Utility of Graves’ Disease Treatments at Damnoensaduak Hospital”. Journal of Medicine and Health Science2 (2012): 38-45.
    12. Tongsiri Sirinart. Valuing Preferences for EQ-5D Health States in the Thai General Population. N.p., (2009).
    13. Sakthong Phantipa., et al. “A Comparison of EQ-5D Index Scores Using the UK, US, and Japan Preference Weights in a Thai Sample with Type 2 Diabetes”. Health and Quality of Life Outcomes 6 (2008): 71.
    14. Cooper David S. “Antithyroid Drugs in the Management of Patients with Graves’ Disease: An Evidence-Based Approach to Therapeutic Controversies”. The Journal of Clinical Endocrinology and Metabolism 8 (2003): 3474-3481.
    15. Sundaresh Vishnu., et al. “Comparative Effectiveness of Therapies for Graves’ Hyperthyroidism: A Systematic Review and Network Meta-A Nalysis”. Journal of Clinical Endocrinology and Metabolism 9 (2013): 3671-3677.
    16. Ross Douglas S. “Radioiodine Therapy for Hyperthyroidism”. New England Journal of Medicine (2011): 542-550.
    17. Braga Milena., et al. “The Effect of Methimazole on Cure Rates after Radioiodine Treatment for Graves’ Hyperthyroidism: A Randomized Clinical Trial”. Thyroid2 (2002): 135-139.
    18. Alexander Erik K and P Reed Larsen. “High Dose 131 I Therapy for the Treatment of Hyperthyroidism Caused by Graves’ Disease”. The Journal of Clinical Endocrinology and Metabolism 3 (2002): 1073-1077.
    19. Ma Chao., et al. “Radioiodine Therapy versus Antithyroid Medications for Graves’ Disease”. Cochrane Database of Systematic Reviews (2016): CD010094.
Citation: Phisan Chumchuen., et al. “Health Utility of Patients with Graves’ Disease after Two-Year Treatment with Anti-Thyroid Drugs and Radioactive Iodine: a Prospective Study”. EC Nursing and Healthcare 3.3 (2021): 238-244.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.